Literature DB >> 16633128

Probiotics and the immune response.

Karen Madsen1.   

Abstract

Beneficial effects exerted by probiotic bacteria in the treatment of human disease may be broadly classified as those effects which arise due to activity in the large intestine and are related to colonization or inhibition of pathogen growth; and those effects which arise in both the small and large intestine, and are related to enhancement of the host immune response and intestinal barrier function. In a strain dependent fashion, probiotic bacteria can enhance intestinal barrier function and modulate signal transduction pathways and gene expression in epithelial and immune cells. Oral administration of live probiotics and bacterial structural components can also differentially modulate dendritic cells resulting in an increased production of IL-10 and regulatory T cells. Both innate and adaptive immune responses can be modulated by probiotic bacteria.

Entities:  

Mesh:

Year:  2006        PMID: 16633128     DOI: 10.1097/00004836-200603000-00014

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  19 in total

1.  Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.

Authors:  Thu A Chau; Michelle L McCully; William Brintnell; Gary An; Katherine J Kasper; Enrique D Vinés; Paul Kubes; S M Mansour Haeryfar; John K McCormick; Ewa Cairns; David E Heinrichs; Joaquín Madrenas
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

Review 2.  Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research.

Authors:  Jens Walter
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

3.  Current level of consensus on probiotic science--report of an expert meeting--London, 23 November 2009.

Authors:  Ian Rowland; Lucio Capurso; Kevin Collins; John Cummings; Nathalie Delzenne; Olivier Goulet; Francisco Guarner; Philippe Marteau; Rémy Meier
Journal:  Gut Microbes       Date:  2010 Nov-Dec

4.  Probiotics and ileitis: could augmentation of TNF/NFκB activity be the answer?

Authors:  Christian Jobin
Journal:  Gut Microbes       Date:  2010-05-26

5.  Modulation of the gut microbiota with antibiotic treatment suppresses whole body urea production in neonatal pigs.

Authors:  Patrycja Puiman; Barbara Stoll; Lars Mølbak; Adrianus de Bruijn; Henk Schierbeek; Mette Boye; Günther Boehm; Ingrid Renes; Johannes van Goudoever; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-11-08       Impact factor: 4.052

6.  Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial.

Authors:  Kulandaipalayam N C Sindhu; Thuppal V Sowmyanarayanan; Anu Paul; Sudhir Babji; Sitara S R Ajjampur; Sophia Priyadarshini; Rajiv Sarkar; K A Balasubramanian; Christine A Wanke; Honorine D Ward; Gagandeep Kang
Journal:  Clin Infect Dis       Date:  2014-02-05       Impact factor: 9.079

7.  Probiotic Bio-Three induces Th1 and anti-inflammatory effects in PBMC and dendritic cells.

Authors:  Man-Chin Hua; Tzou-Yien Lin; Ming-Wei Lai; Man-Shan Kong; Hung-Ju Chang; Chien-Chang Chen
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

8.  Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis.

Authors:  Joshua M Uronis; Janelle C Arthur; Temitope Keku; Anthony Fodor; Ian M Carroll; Myrella L Cruz; Caroline B Appleyard; Christian Jobin
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

9.  Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents.

Authors:  J Ezendam; A de Klerk; E R Gremmer; H van Loveren
Journal:  Clin Exp Immunol       Date:  2008-12       Impact factor: 4.330

10.  Effects of FR-91 on immune cells from healthy individuals and from patients with non-Hodgkin lymphoma.

Authors:  V R M Lombardi; E Martínez; R Chacón; I Etcheverría; R Cacabelos
Journal:  J Biomed Biotechnol       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.